NR3C2 and diabetes mellitus: Patients with early‐NICM that experienced MACE were older, had a higher body mass index, a lower proportion were Caucasian and a higher proportion had diabetes mellitus, prior non‐sustained VT and were treated with ACEi/ARB, beta‐blockers or mineralocorticoid receptor antagonists compared to those with early‐NICM that did not experience MACE.